NFKB1 and Parkinson disease: Although the impact of NF-kB has been described in several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [20], its role in SAH-induced DCI and neurologic outcome has not been explored in detail.